Increased IL-17A secreting CD4+ T cells, serum IL-17 levels and exhaled nitric oxide are correlated with childhood asthma severity

Clinical and Experimental Allergy

Volumn 43, Issue 9, 2013, Pages 1018-1026

  Chien, J W ^a   Lin, C Y ^b,c   Yang, K D ^d,e   Lin, C H ^a,f,g   Kao, J K ^a   Tsai, Y G ^a,g  

^a CHANGHUA CHRISTIAN HOSPITAL   (Taiwan)

^b CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^c CHINA MEDICAL UNIVERSITY   (Taiwan)

^d SHOW CHWAN MEMORIAL HOSPITAL   (Taiwan)

^e NATIONAL YANG MING UNIVERSITY   (Taiwan)

^f CHANG JUNG CHRISTIAN UNIVERSITY   (Taiwan)

^g CHUNG SHAN MEDICAL UNIVERSITY   (Taiwan)

Author keywords

C ACT; IL 17; Nitric oxide

Indexed keywords

INTERLEUKIN 17; NEUTRALIZING ANTIBODY; NITRIC OXIDE;

ADOLESCENT; ADULT; ARTICLE; ASTHMA; CD4+ T LYMPHOCYTE; CHILD; CHILDHOOD DISEASE; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; HUMAN; IMMUNOTHERAPY; LUNG FUNCTION; MAJOR CLINICAL STUDY; MALE; PERIPHERAL BLOOD MONONUCLEAR CELL; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RESPIRATORY TRACT INFLAMMATION; SCHOOL CHILD;

C-ACT; IL-17; NITRIC OXIDE;

ADOLESCENT; ASTHMA; CD4-POSITIVE T-LYMPHOCYTES; CHILD; CHILD, PRESCHOOL; EXHALATION; FEMALE; HUMANS; INTERLEUKIN-17; MALE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE II; RESPIRATORY FUNCTION TESTS; SEVERITY OF ILLNESS INDEX; SPUTUM; TH17 CELLS;

EID: 84882771510     PISSN: 09547894     EISSN: 13652222     Source Type: Journal    
DOI: 10.1111/cea.12119     Document Type: Article

References (45)

1. Miossec P, Korn T, Kuchroo VK. Interleukin-17 and type 17 helper T cells. N Engl J Med 2009; 361:888-98.
2. Maddur MS, Miossec P, Kaveri SV, Bayry J. Th17 cells: biology, pathogenesis of autoimmune and inflammatory diseases, and therapeutic strategies. Am J Pathol 2012; 181:8-18.
3. Wilke CM, Bishop K, Fox D, Zou W. Deciphering the role of Th17 cells in human disease. Trends Immunol 2011; 32:603-11.
4. Cosmi L, Liotta F, Maggi E, Romagnani S, Annunziato F. Th17 cells: new players in asthma pathogenesis. Allergy 2011; 66:989-98.
5. Park H, Li Z, Yang XO et al. A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17. Nat Immunol 2005; 6:1133-41.
6. Pène J, Chevalier S, Preisser L et al. Chronically inflamed human tissues are infiltrated by highly differentiated Th17 lymphocytes. J Immunol 2008; 180:7423-30.
7. Zijlstra GJ, Ten Hacken NH, Hoffmann RF, van Oosterhout AJ, Heijink IH. Interleukin-17A induces glucocorticoid insensitivity in human bronchial epithelial cells. Eur Respir J 2012; 39:439-45.
8. Bullens DM, Truyen E, Coteur L et al. IL-17 mRNA in sputum of asthmatic patients: linking T cell driven inflammation and granulocytic influx? Respir Res 2006; 7:135.
9. Doe C, Bafadhel M, Siddiqui S et al. Expression of the T helper 17-associated cytokines IL-17A and IL-17F in asthma and COPD. Chest 2010; 138:1140-7.
10. Souwer Y, Szegedi K, Kapsenberg ML, de Jong EC. IL-17 and IL-22 in atopic allergic disease. Curr Opin Immunol 2010; 22:821-6.
11. Finkelman FD, Hogan SP, Hershey GK, Rothenberg ME, Wills-Karp M. Importance of cytokines in murine allergic airway disease and human asthma. J Immunol 2010; 184:1663-74.
12. Molet S, Hamid Q, Davoine F et al. IL-17 is increased in asthmatic airways and induces human bronchial fibroblasts to produce cytokines. J Allergy Clin Immunol 2001; 108:430-8.
13. Al-Ramli W, Préfontaine D, Chouiali F et al. T(H)17-associated cytokines (IL-17A and IL-17F) in severe asthma. J Allergy Clin Immunol 2009; 123:1185-7.
14. Bartemes KR, Kita H. Dynamic role of epithelium-derived cytokines in asthma. Clin Immunol 2012; 143:222-35.
15. Harrington LE, Hatton RD, Mangan PR et al. Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages. Nat Immunol 2005; 6:1123-32.
16. Cosmi L, Maggi L, Santarlasci V et al. Identification of a novel subset of human circulating memory CD4+ T cells that produce both IL-17A and IL-4. J Allergy Clin Immunol 2010; 125:222-30, e1-4.
17. Stewart L, Katial RK. Exhaled nitric oxide. Immunol Allergy Clin North Am 2012; 32:347-62.
18. Nagy G, Clark JM, Buzás EI, Gorman CL, Cope AP. Nitric oxide, chronic inflammation and autoimmunity. Immunol Lett 2007; 111:1-5.
19. Lane C, Knight D, Burgess S et al. Epithelial inducible nitric oxide synthase activity is the major determinant of nitric oxide concentration in exhaled breath. Thorax 2004; 59:757-60.
20. Waibel V, Ulmer H, Horak E. Assessing asthma control: symptom scores, GINA levels of asthma control, lung function, and exhaled nitric oxide. Pediatr Pulmonol 2012; 47:113-8.
21. Dupont LJ, Rochette F, Demedts MG, Verleden GM. Exhaled nitric oxide correlates with airway hyperresponsiveness in steroid-naive patients with mild asthma. Am J Respir Crit Care Med 1998; 157:894-8.
22. Tsai YG, Lee MY, Yang KD, Chu DM, Yuh YS, Hung CH. A single dose of nebulized budesonide decreases exhaled nitric oxide in children with acute asthma. J Pediatr 2001; 139:433-7.
23. Lee MY, Tsai YG, Yang KD, Hung CH. Comparison of the effects of nebulized terbutaline with or without intravenous betamethasone on exhaled nitric oxide in children with acute asthma attack. J Microbiol Immunol Infect 2006; 39:33-8.
24. Miljković D, Trajković V. Inducible nitric oxide synthase activation by interleukin-17. Cytokine Growth Factor Rev 2004; 15:21-32.
25. Shin TS, Lee BJ, Tae YM et al. Role of inducible nitric oxide synthase on the development of virus-associated asthma exacerbation which is dependent on Th1 and Th17 cell responses. Exp Mol Med 2010; 42:721-30.
26. Mühl H, Bachmann M, Pfeilschifter J. Inducible NO synthase and antibacterial host defence in times of Th17/Th22/T22 immunity. Cell Microbiol 2011; 13:340-8.
27. Liu AH, Zeiger R, Sorkness C et al. Development and cross-sectional validation of the childhood asthma control test. J Allergy Clin Immunol 2007; 119:817-25.
28. Tsai YG, Chien JW, Chen WL et al. Induced apoptosis of TH2 lymphocytes in asthmatic children treated with Dermatophagoides pteronyssinus immunotherapy. Pediatr Allergy Immunol 2005; 16:602-8.
29. Wang YH, Voo KS, Liu B et al. A novel subset of CD4(+) T(H)2 memory/effector cells that produce inflammatory IL-17 cytokine and promote the exacerbation of chronic allergic asthma. J Exp Med 2010; 207:2479-91.
30. Steinman L. A brief history of T(H)17, the first major revision in the T(H)1/T(H)2 hypothesis of T cell-mediated tissue damage. Nat Med 2007; 13:139-45.
31. Agache I, Ciobanu C, Agache C, Anghel M. Increased serum IL-17 is an independent risk factor for severe asthma. Respir Med 2010; 104:1131-7.
32. Alcorn JF, Crowe CR, Kolls JK. TH17 cells in asthma and COPD. Annu Rev Physiol 2010; 72:495-516.
33. Zhao Y, Yang J, Gao YD, Guo W. Th17 immunity in patients with allergic asthma. Int Arch Allergy Immunol 2010; 151:297-307.
34. Chang Y, Al-Alwan L, Risse PA et al. TH17 cytokines induce human airway smooth muscle cell migration. J Allergy Clin Immunol 2011; 127:1046-53, e1-2.
35. Barczyk A, Pierzchala W, Sozañska E. Interleukin-17 in sputum correlates with airway hyperresponsiveness to methacholine. Respir Med 2003; 97:726-33.
36. Edwards MR, Bartlett NW, Clarke D, Birrell M, Belvisi M, Johnston SL. Targeting the NF-kappaB pathway in asthma and chronic obstructive pulmonary disease. Pharmacol Ther 2009; 121:1-13.
37. Wong CK, Cao J, Yin YB, Lam CW. Interleukin-17A activation on bronchial epithelium and basophils: a novel inflammatory mechanism. Eur Respir J 2010; 35:883-93.
38. Fitzpatrick AM, Baena-Cagnani CE, Bacharier LB. Severe asthma in childhood: recent advances in phenotyping and pathogenesis. Curr Opin Allergy Clin Immunol 2012; 12:193-201.
39. Green RH, Brightling CE, Bradding P. The reclassification of asthma based on subphenotypes. Curr Opin Allergy Clin Immunol 2007; 7:43-50.
40. Kim HY, DeKruyff RH, Umetsu DT. The many paths to asthma: phenotype shaped by innate and adaptive immunity. Nat Immunol 2010; 11:577-84.
41. Aytekin M, Dweik RA. Nitric oxide and asthma severity: towards a better understanding of asthma phenotypes. Clin Exp Allergy 2012; 42:614-6.
42. Dweik RA, Sorkness RL, Wenzel S et al. Use of exhaled nitric oxide measurement to identify a reactive, at-risk phenotype among patients with asthma. Am J Respir Crit Care Med 2010; 181:1033-41.
43. Yamamoto M, Tochino Y, Chibana K, Trudeau JB, Holguin F, Wenzel SE. Nitric oxide and related enzymes in asthma: relation to severity, enzyme function and inflammation. Clin Exp Allergy 2012; 42:760-8.
44. Szefler SJ, Wenzel S, Brown R et al. Asthma outcomes: biomarkers. J Allergy Clin Immunol 2012; 129:S9-23.
45. Yavuz ST, Civelek E, Sahiner UM et al. Identifying uncontrolled asthma in children with the childhood asthma control test or exhaled nitric oxide measurement. Ann Allergy Asthma Immunol 2012; 109:36-40.